Galmed Pharmaceuticals Ltd

NEW
FRA:GPH (Israel)  
€ 21.89 (0%) Sep 7
At Loss
P/B:
0.04
Market Cap:
€ 3.57M ($ 4.15M)
Enterprise V:
€ -5.99M ($ -6.96M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Galmed Pharmaceuticals Ltd (FRA:GPH) Dividend

Galmed Pharmaceuticals Ltd (FRA:GPH) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -257.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:GPH Dividend

Does Galmed Pharmaceuticals Ltd (FRA:GPH) pay a dividend?

Galmed Pharmaceuticals Ltd (FRA:GPH) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Galmed Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Galmed Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -257.6% over the past 3 years.

What are dividend-paying alternatives to Galmed Pharmaceuticals Ltd?

For dividend-paying alternatives in Galmed Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.